Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
09/2005
09/29/2005CA2557295A1 Improved bacterial host cell for the direct expression of peptides
09/29/2005CA2557174A1 Albumin-purification method comprising a nanofiltration step, solution, and composition for therapeutic use containing same
09/29/2005CA2556080A1 Novel tat complexes, and vaccines comprising them
09/29/2005CA2552508A1 Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions
09/29/2005CA2546157A1 Improved expression systems with sec-system secretion
09/28/2005EP1580282A1 Use of human RPS6KA6-related gene variant for diagnosing T cell lymphoblastic lymphoma
09/28/2005EP1580276A1 Packaging cell system for eb virus vector
09/28/2005EP1580275A1 Plants having improved growth characteristics and method for making the same
09/28/2005EP1580273A1 Peptide-based method for monitoring gene expression in a host cell
09/28/2005EP1580272A2 TAT transdominant variants of human immunodeficiency virus (HIV)
09/28/2005EP1580271A2 Human Orphan G Protein-Coupled Receptors
09/28/2005EP1580266A1 Screening method
09/28/2005EP1580263A1 Full-length cDNA sequences
09/28/2005EP1580262A1 Method for producing L-amino acid
09/28/2005EP1580195A1 Compositions of polypeptides specific to pathogenic ExPEC E. coli strains and their use as vaccines and in immunotherapy
09/28/2005EP1579871A1 Vascular endothelial cell growth factor antagonists and uses thereof
09/28/2005EP1579221A2 Uses of hmgb, hmgn, hmga proteins
09/28/2005EP1579212A2 Methods of identifying reduced internalization transmembrane receptor agonists
09/28/2005EP1579010A2 Susceptibility gene for myocardial infarction; methods of treatment
09/28/2005EP1578996A2 Compositions and methods for the diagnosis and treatment of tumor
09/28/2005EP1578992A2 Methods of determining precise herg interactions and aletring compounds based on said interactions
09/28/2005EP1578990A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
09/28/2005EP1578989A2 Novel nucleic acids and secreted polypeptides
09/28/2005EP1578988A2 Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders
09/28/2005EP1578981A2 Tumor endothelial marker 7alpha molecules and uses thereof
09/28/2005EP1578980A2 Nucleic acid and corresponding protein entitled 213p1f11 useful in treatment and detection of cancer
09/28/2005EP1578977A2 Method for altering the content of reserve substances in plants
09/28/2005EP1578976A2 Plants having modified growth characteristics and a method for making the same
09/28/2005EP1578972A2 Genes and proteins for the biosynthesis of the glycopeptide antibiotic a40926
09/28/2005EP1578971A2 Stress-related polypeptides and uses therefor
09/28/2005EP1578970A1 Human autoantigens and use thereof
09/28/2005EP1578967A1 Fluorescent proteins from aquatic species
09/28/2005EP1578962A2 Carrier-ligand fusions and uses thereof
09/28/2005EP1578956A2 Highly permissive cell lines for hepatitis c virus replication
09/28/2005EP1578949A2 Site specific incorporation of keto amino acids into proteins
09/28/2005EP1578948A2 Flj10607 as modifier of the axin pathway and methods of use
09/28/2005EP1578934A2 FLJ20647s AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE
09/28/2005EP1578930A2 Cngh0004 polypeptides, antibodies, compositions, methods and uses
09/28/2005EP1578928A2 Metalloprotease activation of myostatin, and methods of modulating myostatin activity
09/28/2005EP1578926A2 Novel prostate tumor-specific promoter
09/28/2005EP1578923A2 Soluble mic polypeptides as markers for diagnosis, prognosis and treatment of cancer and autoimmune diseases or conditions
09/28/2005EP1578922A2 Replikin peptides in rapid replication of glioma cells and in influenza epidemics
09/28/2005EP1578921A2 Mammalian migration inducting gene and methods for detection and inhibition of migrating tumor cells
09/28/2005EP1578920A2 Composition and method for modulating an inflammatory response
09/28/2005EP1578919A2 Endogenous retrovirus up-regulated in prostate cancer
09/28/2005EP1578917A2 Multimeric proteins and methods of making and using same
09/28/2005EP1578916A2 Human ras interacting protein
09/28/2005EP1578915A2 Methods for inhibiting proliferation of astrocytes and astrocytic tumor cells and for enhancing survival of neurons and uses thereof
09/28/2005EP1578914A2 Human ion channels
09/28/2005EP1578913A2 Nucleic acids and proteins of insect or83b odorant receptor genes and uses thereof
09/28/2005EP1578912A2 Il-13 mutein proteins, antibodies, compositions, methods and uses
09/28/2005EP1578911A2 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
09/28/2005EP1578909A2 Excitatory glycine receptors and methods
09/28/2005EP1578908A2 Human schizophrenia gene
09/28/2005EP1578907A2 Secreted protein, ztnf9
09/28/2005EP1578906A2 Afap sequences, polypeptides, antibodies and methods
09/28/2005EP1578902A2 Neurotransmission-associated proteins
09/28/2005EP1578900A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
09/28/2005EP1578899A2 Secreted proteins
09/28/2005EP1578846A2 Gluten biopolymers
09/28/2005EP1578798A1 Ghrelin receptor inverse agonist for regulation of feeding behaviours
09/28/2005EP1578797A1 The transmembrane protein amigo and uses thereof
09/28/2005EP1578796A2 Chorionic somatomammotropin hormone splice variants
09/28/2005EP1578795A1 Il-8-like proteins
09/28/2005EP1578794A1 A novel phosphoprotein
09/28/2005EP1578793A1 Soluble complexes of target proteins and peptidyl prolyl isomerase chaperones and methods of making and using them
09/28/2005EP1578792A2 Novel centrosome-associated protein and applications thereof
09/28/2005EP1578791A2 Inclusion bodies for the oral vaccination of animals
09/28/2005EP1578790A2 A novel gene osisap1 of rice confers tolerance to stresses and a method thereof
09/28/2005EP1578789A1 Nucleic acid comprising a sequence encoding a modified glutenin polypeptide
09/28/2005EP1578788A2 Pseudomonas aeruginosa and klebsiella virulence genes, proteins, and their use
09/28/2005EP1578785A1 Peptides that bind to the heparin binding domain of vegf and vegfr-2
09/28/2005EP1578784A2 Peptides that bind to the vegfr-2
09/28/2005EP1578778A2 Ghrelin analogs
09/28/2005EP1578776A2 Products for regulating the degradation of collagen and methods for indentifying same
09/28/2005EP1578775A2 Novel compositions and methods for the generation of mhc class ii compounds by peptide exchange
09/28/2005EP1578773A2 Methods and products based on oligomerization of stress proteins
09/28/2005EP1578772A2 Cytokines and cytokine receptors with reduced immunogenicity
09/28/2005EP1578771A2 Remodeling and glycoconjugation of peptides
09/28/2005EP1578770A2 Novel human egf-family proteins and polynucleotides encoding the same
09/28/2005EP1578768A2 Novel peptide dimers as agonists of the erythropoietin (epo) receptor, and associated methods of synthesis and use
09/28/2005EP1578766A2 Polyvalent, primary hiv-1 glycoprotein dna vaccines and vaccination methods
09/28/2005EP1578762A2 A novel pth responsive gene
09/28/2005EP1578760A2 Compositions and methods for the diagnosis and treatment of tumor
09/28/2005EP1578480A2 Antagonists for human prolactin
09/28/2005EP1578452A2 Nucleic acids, polypeptides, and methods for modulating apoptosis
09/28/2005EP1578439A2 Low dose methods for treating disorders in which tnf-alpha activity is detrimental
09/28/2005EP1578436A2 Saposing c and receptors as targets for treatment of benign and malignant disorders
09/28/2005EP1578432A2 Hla binding peptides and their uses
09/28/2005EP1578385A2 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
09/28/2005EP1578382A2 Botulinum neurotoxin b receptors and use thereof
09/28/2005EP1578381A2 Chemokine antagonists and uses thereof
09/28/2005EP1578380A2 Compositions and methods for the therapy and diagnosis of prostate cancer
09/28/2005EP1578374A2 Escape mutants of newcastle disease virus as marker vaccines
09/28/2005EP1578373A2 Novel compositions and methods for the treatment of immune related diseases
09/28/2005EP1578372A2 Ca125 gene and its use for diagnostic and therapeutic interventions
09/28/2005EP1578368A2 Compositions and methods for the treatment of rheumatoid arthritis
09/28/2005EP1578367A2 Compositions and methods for the treatment of immune related diseases
09/28/2005EP1578365A2 Molecular interactions in neurons
09/28/2005EP1578364A2 Compositions and methods for the treatmentof immune related diseases
1 ... 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 ... 2916